Challenges of Prescribing Low-dose Drug Therapy for Older People

Overview

Journal CMAJ

Date 1999 Apr 20

PMID 10207345

Citations 4

Authors

P A Rochon

J P Clark

J H Gurwitz

Affiliations

Soon will be listed here.

Citing Articles

Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.

Rochon P, Gruneir A, Bell C, Savage R, Gill S, Wu W PLoS One. 2018; 13(10):e0205524.

PMID: 30346974 PMC: 6197851. DOI: 10.1371/journal.pone.0205524.

A composite screening tool for medication reviews of outpatients: general issues with specific examples.

De Smet P, Denneboom W, Kramers C, Grol R Drugs Aging. 2007; 24(9):733-60.

PMID: 17727304 DOI: 10.2165/00002512-200724090-00003.

The practice of splitting tablets: cost and therapeutic aspects.

Bachynsky J, Wiens C, Melnychuk K Pharmacoeconomics. 2002; 20(5):339-46.

PMID: 11994043 DOI: 10.2165/00019053-200220050-00005.

Pill-splitting in a long-term care facility.

Fischbach M, Gold J, Lee M, Dergal J, Litner G, Rochon P CMAJ. 2001; 164(6):785-6.

PMID: 11276544 PMC: 80873.

References

Wilcox R, Roland J, Banks D, Hampton J, Mitchell J . Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J. 1980; 280(6218):885-8. PMC: 1601074. DOI: 10.1136/bmj.280.6218.885. View

Bugeja G, Kumar A, Banerjee A . Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ. 1997; 315(7115):1059. PMC: 2127695. DOI: 10.1136/bmj.315.7115.1059. View

Vardan S, Mehrotra K, Mookherjee S, Willsey G, Gens J, Green D . Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study. JAMA. 1987; 258(4):484-8. DOI: 10.1001/jama.1987.03400040082026. View

Nolan L, OMalley K . Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988; 36(2):142-9. DOI: 10.1111/j.1532-5415.1988.tb01785.x. View

McVeigh G, Galloway D, Johnston D . The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. BMJ. 1988; 297(6641):95-8. PMC: 1833832. DOI: 10.1136/bmj.297.6641.95. View

Yusuf S, Wittes J, Friedman L . Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA. 1988; 260(14):2088-93. View

Grymonpre R, Mitenko P, Sitar D, Aoki F, Montgomery P . Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988; 36(12):1092-8. DOI: 10.1111/j.1532-5415.1988.tb04395.x. View

Col N, Fanale J, Kronholm P . The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150(4):841-5. View

Carlsen J, Kober L, Torp-Pedersen C, Johansen P . Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990; 300(6730):975-8. PMC: 1662719. DOI: 10.1136/bmj.300.6730.975. View

10.

Gurwitz J, Avorn J . The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991; 114(11):956-66. DOI: 10.7326/0003-4819-114-11-956. View

11.

Johnston G, Wilson R, McDermott B, McVeigh G, Duffin D, Logan J . Low-dose cyclopenthiazide in the treatment of hypertension: a one-year community-based study. Q J Med. 1991; 78(286):135-43. View

12.

Dahlof B, Lindholm L, Hansson L, SCHERSTEN B, Ekbom T, Wester P . Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991; 338(8778):1281-5. DOI: 10.1016/0140-6736(91)92589-t. View

13.

Gurwitz J, Col N, Avorn J . The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992; 268(11):1417-22. View

14.

Forman D, Bernal J, Wei J . Management of acute myocardial infarction in the very elderly. Am J Med. 1992; 93(3):315-26. DOI: 10.1016/0002-9343(92)90240-c. View

15.

Rochon P, Fortin P, Dear K, Minaker K, CHALMERS T . Reporting of age data in clinical trials of arthritis. Deficiencies and solutions. Arch Intern Med. 1993; 153(2):243-8. View

16.

Trimble E, Carter C, Cain D, Freidlin B, Ungerleider R, Friedman M . Representation of older patients in cancer treatment trials. Cancer. 1994; 74(7 Suppl):2208-14. DOI: 10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-#. View

17.

McCrory D, Matchar D, Samsa G, Sanders L, Pritchett E . Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995; 155(3):277-81. View

18.

Hylek E, Skates S, Sheehan M, Singer D . An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996; 335(8):540-6. DOI: 10.1056/NEJM199608223350802. View

19.

Aronow W . Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc. 1996; 44(9):1075-7. DOI: 10.1111/j.1532-5415.1996.tb02941.x. View

20.

Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L . Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997; 277(2):115-21. View